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Toxicity of Vinyl Chloride and PoIy(vinyl
Chloride): A Critical Review
by Joseph K. Wagoner*
In 1974, vinyl chloride (VC) was first reported in the open scientific literature to induce
angiosarcoma of the liver both in humans and in animals. Additional research has now
demonstrated the carcinogenicity ofVC to other organs and at lower concentrations. The
target organs for VC now clearly include the liver, brain and the lung, and probably the
lymphohematopoietic system.
The evidence for a carcinogenic risk has been extended to jobs associated with
poly(vinyl chloride) exposure. Cases of liver angiosarcoma have been reported among
individuals employed in PVC fabrication facilities and an epidemiological study has
demonstrated a significant association between exposure to PVC dust and the risk oflung
cancer mortality. Cases of angiosarcoma of the liver also have been reported among
individuals living in near proximity to vinyl chloride-poly(vinyl chloride) plants.
An association between PVC dust and pneumoconiosis also has been demonstrated. On
the basis offindings, prudent control ofPVC dust in the industrial setting is indicated.
Laboratory Bioassay
In 1971, 44 years after vinyl chloride was intro-
duced into American commerce (1), 24 years after
vinyl chloride was shown to cause cardiac
arrhythmia in experimental animals (2), 22 years
after vinyl chloride was reported to be associated
with hepatic abnormalities in workers in a Rus-
sian plastic factory (3), 14 years after toxic an-
gioneuropathy was noted among workers exposed
to vinyl chloride below the then Russian maxi-
mum allowable concentration of 390 ppm (4), 11
years after the vinyl chloride production process
was associated with a severe neurologic disorder
in Minamata, Japan (5), 10 years after vinyl
chloride at concentrations down to 200 ppm were
reported to cause centrilobular granular de-
generation ofthe liver (6) and 5 years after vinyl
chloride was shown to induce acro-osteolysis in
workers cleaning reactor vessels (7), Viola et al.
(8) reported the induction of tumors of the skin,
lung and bone in rats exposed by inhalation to
30,000 ppm ofvinyl chloride.
These oncogenic findings have been interpreted
by some to have elicited little response because
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the testing was conducted only at unrealistically
high dosages bordering on the lower explosive
limit of vinyl chloride (9). In reality, however,
such was not the case. In May of 1971, Viola had
presented to several U.S. companies unpublished
findings of an increased incidence of tumors in
rats exposed to vinyl chloride concentrations
down to and including 500 ppm (10). Additional
ongoing studies involving vinyl chloride expo-
sures of20,000, 10,000, 5,000, 2,000, 500 and less
than 500 ppm were also described to those same
companies. In like manner, Maltoni, in 1972,
upon noting angiosarcoma ofthe liver and cancer
of other sites in rats exposed by inhalation to
vinyl chloride at lower concentrations, also had
transmitted his findings to the Manufacturing
Chemists Association in the United States and to
several chemical companies in Europe (11). Gov-
ernment, labor and the independent research
community were first informed of the expanding
carcinogenic properties ofvinyl chloride in Janu-
ary of 1974, when representatives of industry
announced having found liver angiosarcoma in
three workers who had cleaned reactor vessels as
part of their employment at a single vinyl chlo-
ride polymerization facility in the United States.
Almost simultaneously, findings of the induction
of liver angiosarcoma in rats exposed to vinyl
chloride were made public.J. K. WAGONER
The carcinogenic properties of vinyl chloride
were further clarified in 1974, when Caputo et al.
(12) reported an increasing incidence ofliver an-
giosarcoma with an increasing dosage of vinyl
chloride. Among rats exposed to vinyl chloride by
inhalation, the incidence of liver angiosarcoma
was 3% at 500, 5% at 1,000, 6% at 5,000, 8% at
10,000 and 12% at 20,000 ppm. Among controls
not exposed to vinyl chloride, liver angiosarcoma
was not found. In that same year Maltoni and
Lefemine (13) also reported the induction of tu-
mors in mice, hamsters and rats exposed to vinyl
chloride by inhalation. The spectrum of induced
tumors included angiosarcomas ofthe liver, ade-
nomas and adenocarcinomas of the lung, neuro-
blastomas of the brain, lymphomas and carcino-
mas of other sites. Vinyl chloride in that study
was shownto induce liver angiosarcoma in rats at
50 ppm of exposure. Keplinger et al. (14) in that
same year also reported the induction of liver
angiosarcoma in mice exposed to 50 ppm ofvinyl
chloride by inhalation. Subsequently, Holmberg
et al. (15) reported the induction of hepatic and
extrahepatic angiosarcoma in mice following in-
halation exposure to vinyl chloride at 50 ppm.
Shortly thereafter Maltoni (16) extended the car-
cinogenicity of vinyl chloride to lower levels of
exposure. Vinyl chloride administered by inhala-
tion was shown to induce tumors at a variety of
sites, including liver angiosarcoma at 25 ppm and
mammary carcinomas at 25, 10, 5 and 1 ppm.
Recently Maltoni (17) reported the induction of
hepatic and extrahepatic angiosarcoma at 10 ppm
ofvinyl chloride.
Epidemiology
Occupational Exposure: Vinyl
Chloride Production or
Polymerization
In 1974, the same year that the public was first
informed that vinyl chloride induced liver an-
giosarcoma and cancers of other sites by way of
experimental bioassay, epidemiological studies
also were reported demonstrating an excess of
cancer ofmultiple organs among workers occupa-
tionally exposed to vinyl chloride. Tabershaw and
Gaffey (18) reported that cancers of the buccal
cavity and pharynx, digestive tract (primarily
liver angiosarcoma), respiratory tract, central
nervous system (primarily brain) and the lym-
phatic system were excessive among workers in
the United States having been employed for at
least one year in plants producing and/or polym-
erizing vinyl chloride. Monson et al. (19) in that
same year reported the results ofa proportionate
mortality analysis of 161 deceased workers hav-
ing been employed at one of two plants in the
United States producing and polymerizing vinyl
chloride. The specific sites of cancer with the
greatest excess were the liver and biliary tract,
with an 11-fold excess; the brain, with a 4-fold
excess; the digestive tract and the lung.
In 1975, Nicholson et al. (20) published a study
of cancer mortality among 257 individuals occu-
pationally exposed to vinyl chloride for at least 5
years, with the initial exposure having occurred
more than 10 years in the past during employ-
ment in a U.S. plant polymerizing vinyl chloride.
A 2.3-fold excess in deaths from cancer ofall sites
combined was demonstrated with three deaths
due tohemangiosarcoma ofthe liver. Inthat same
year, Ott et al. (21) reported the mortality experi-
ence of549 individuals occupationally exposed to
vinyl chloride-poly(vinyl chloride). Whereas no
angiosarcomas ofthe liver were found, an excess
ofall malignancies combined wasreported among
those workers classified as having been highly
exposed when contrasted with workers of all
other exposure intensities. Among the nine can-
cerdeaths inthe highly exposed group ofworkers,
four were due to lung cancer. In a discussion of
the limitations of the study, the investigators
noted that the majority ofworkers in the category
"other than highly exposed" had less than one
year ofwork experience in departments with ex-
posure to vinyl chloride-polyvinyl chloride.
Duck et al. (22) in 1975 reported that a study of
2100 employees ofa vinyl chloride polymerization
plant in the United Kingdom revealed no excess
oftotal or cause-specific mortality. In addition to
reporting no excess of cancer mortality. The in-
vestigators reported an inverse relation between
vinyl chloride exposure and cancer mortality, i.e.,
as the duration of exposure to vinyl chloride-
poly(vinyl chloride) increased, the risk of cancer
decreased. The results and conclusions of that
study were adjudged by Wagoner et al. (23) to be
spurious and due to the use of faculty analytical
methodology. Upon reanalysis ofthe data in that
study, Duck and Carter (24) reported an in-
creased risk of cancer of the digestive system
among workers observed 15 years or more after
onset of exposure to vinyl chloride-poly(vinyl
chloride).
Subsequently, Waxweiler et al. (25) reported
the results of a retrospective study of mortality
among a cohort of 1294 workers occupationally
exposed to vinyl chloride in the United States.
-Since occupationally induced cancers often take
years to become clinically manifest following ex-
posure to carcinogens, the study was restricted toTOXICITY OF VINYL CHLORIDE AND PVC
those individuals with 5 years or more ofemploy-
ment in departments andjobs directly involving
vinyl chloride exposure andwith 10 years ormore
elapsed time since onset of initial exposure. Spe-
cific jobs and departments with vinyl chloride
exposure were determined following a walk-
through survey and review ofthe manufacturing
process, engineering controls and air-sampling
data for the plants studied. When analyses were
based on the total study cohort, only two major
causes of death were in excess: nonneoplastic
respiratory disease (6 observed vs. 3.4 expected)
and all malignant neoplasms combined (35 ob-
served vs. 23.4 expected). The latter excess was
statistically significant atp = 0.05. When analy-
ses were made according to site of malignancy
and latency (interval since onset ofexposure), an
excess cancer mortality was found for four organ
systems, i.e., central nervous system, respiratory
system, hepatic system and lymphatic and hema-
topoietic system. The excessive mortality was sta-
tistically significant for three of the four organ
systems,, i.e., cancer of the central nervous, the
respiratory and the hepatic systems, among
workers who had been observed 15 years or more
since onset ofexposure. During the course ofthe
study by Waxweiler et al., an evaluation was
made ofthe pathologic data underlying each neo-
plasm identified. Of the 14 cases of liver cancer
identified, 11 were diagnosed as angiosarcoma. Of
ten cases of brain cancer identified, nine were
shown to be glioblastoma multiforme in type.
Furthermore, ofeight lung cancer caseshistologi-
cally confirmed, all were large cell undifferenti-
ated or adenocarcinoma in type.
Byren et al. (26) in 1976 also reported a statisti-
cally significant excess of liver-pancreatic and
brain cancer deaths among 771 workers employed
in a Swedish vinyl chloride/poly(vinyl chloride)
production plant. These investigators reported
that this excess appeared within the first 5 years
after onset ofexposure to vinyl chloride.
In 1977, von Reinl et al. (27) reported the
results ofa study ofcancer mortality among 7021
males employed in the production and polymeri-
zation of vinyl chloride. When compared to the
mortality experience of the West German male
population, vinyl chloride-poly(vinyl chloride)
exposed workers experienced an excess of cancer
ofmultiple organs, i.e., liver, lung, brain and the
lympatic and hematopoietic system. Fox and Col-
lier (28) in 1977 also reported the results of the
study of cancer mortality patterns among 7561
males who, at some time between 1940 and 1974,
were employed at one of four plants producing
poly(vinyl chloride). An excess mortality from
liver cancer was shown for each group ofworkers
whether exposure to vinyl chloride wasjudged to
have been high, medium or low. The authors
commented that, although there were no data
from the study to support an excess mortality
from cancers other than ofthe liver, the period of
follow-up ofthe workers was too short to permit a
clear evaluation of those carcinogenic effects at
that time.
Epidemiological investigations have now
clearly demonstrated that laboratory bioassay
findings were predictive not only for the carcino-
genicity ofvinyl chloride, but also for several ofthe
target organs. On the basis of these results, the
IARC (29) in 1979 concluded "Vinyl chloride is a
human carcinogen. Itstarget organs are the liver,
brain, lung and haemo-lymphopoietic system."
Occupational Exposure: Poly(vinyl
Chloride) Packing and Fabricating
Christine et al. in 1974 reported (30) two histo-
pathologically confirmed cases of hepatic an-
giosarcoma in Connecticut among individuals
who had been employed in industrial facilities
that used poly(vinyl chloride). One ofthese indi-
viduals, a 47-year-old man, had worked for the
previous 10 years as an accountant in a factory
producing vinyl sheets and processing poly(vinyl
chloride) resins. This individual had frequently
visited the plant's production area. The second
individual, a 61-year-old man, had spent 25 years
in an electrical plant operating a machine that
applied poly(vinyl chloride)-containing plastic to
wires. In 1977, Baxter et al. (31), in a review of14
cases ofhepatic angiosarcoma diagnosed in Great
Britain during 1963-73, noted one case who had
worked on a process which used poly(vinyl chlo-
ride) as a raw material.
In 1975, Selikoff wrote to NIOSH suggesting
that appropriate precautions be taken to avoid
the inhalation ofpoly(vinyl chloride) dust, both in
the packaging and transport and in its handling
during the manufacture of poly(vinyl chloride)
products. Selikoff based his suggestion on the
results ofstudies by Lilis et al. (32) and Miller et
al. (33) showing radiographic and pulmonary
fulnction changes among vinyl chlorides-poly(vi-
nyl chloride) workers and on the findings of a
poly(vinyl chloride) inhalation toxicologic study
by Frongia et al. (34). This latter investigation
showed that rats and guinea pigs, exposed in the
same occupational setting as workers who were
employed infilling sacks withpoly(vinyl chloride)
powder, subsequently developed alveolar reac-
tions and septal thickening. This investigation
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also showed that 7 months after their initial
exposure, both species exhibited granulomatous
changes, with fine granules observed intracellu-
larly. Agarwal et al. (35) in 1978 demonstrated
that intratracheal administration of poly(vinyl
chloride) dust in rats resulted in an increase in
the activity oflysomal enzymes, interstitial fibro-
sis and granulomatous lesions surrounded by fi-
broblasts, reticulin and collagen fibers. Pulmo-
nary disorders possibly associated with exposure
to poly(vinyl chloride) resins produced by the
emission process might by expected, as dust sam-
ples taken by NIOSH during the bagging ofpoly-
(vinyl chloride) resin have shown concentrations
ranging from less than 1 up to 19 mg/m3, with
about 90% ofthe particles being smaller than 2.5
gm and 100% smaller than 7 gm in diameter.
In 1978, Arnaud et al. (36) reported a case of
pneumoconiosis in a 53-year-old man who had
been exposed to poly(vinyl chloride) in the bag-
ging area of a VC polymerization plant. This
patient presented with exertional dyspnea, pul-
monary function changes, and chest radiographic
abnormalities. Electron microscopy oflung tissue
obtained by drill biopsy showed foreign particles
inthe macrophages that were identical to poly(vi-
nyl chloride) powder viewed under the electron
microscope. In vitro incubation ofpoly(vinyl chlo-
ride) powder with human lung macrophages
showed that the macrophages engulfed the pow-
der to give an appearance similar to that seen in
vivo. The authors noted that the histological le-
sions in this patient were identical to those re-
corded by Szende et al. (37), who diagnosed ad-
vanced pneumoconiosis in a 31-year-old man
secondary to the inhalation ofpoly(vinyl chloride)
dust. Szende et al. also reported that microscopic
examination ofpoly(vinyl chloride) dust particles
showed them to be morphologically similar to
particles found in the patient's lungs.
Results ofepidemiologic studies by Vertkin and
Hamontov (38) and by Mastrangelo et al. (39)
further support the role ofpoly(vinyl chloride) in
the etiology of pneumoconiosis. A total of 1216
employees of a poly(vinyl chloride) production
factory in Italy underwent chest X-ray examina-
tions. Of731 examined individuals with exposure
to poly(vinyl chloride) dust, 20 were diagnosed as
having pneumoconiosis. All of these individuals
had worked 5 years or more in departments clas-
sified as having poly(vinyl chloride) dust pollu-
tion. No cases of pneumoconiosis were observed
among the 485 examined individuals who worked
in areas free ofpoly(vinyl chloride) dust.
The effects of vinyl chloride-poly(vinyl chlo-
ride) exposure on the respiratory system of ex-
posed workers seem to indicate a pattern of non-
neoplastic effects, a granulomatous reaction to
poly(vinyl chloride) dust, with inclusion of poly-
(vinyl chloride) particles in macrophages and his-
tocytes, and associated interstitial fibrosis.
The long-term carcinogenic effect, with a sig-
nificant increase in lung cancer also is ofconcern.
In 1978, Waxweiler et al. (40) reported the results
of a study of lung cancer at a single vinyl chlo-
ride-poly(vinyl chloride) facility. One objective of
this study was to determine whetherthere was an
excess risk oflung cancer ofa particular histolog-
ical type atthe plant. A case control study showed
a clearexcess oftype 3 (adenocarcinoma) and type
4 (large-cell undifferentiated) lung cancers in
cases occurring among plant employees as com-
pared to other lung cancer cases from the same
hospital ofdiagnosis, matched for age and calen-
dar period of diagnosis. The authors noted that
adenocarcinomas of the lung, accounting for a
minor proportion of this excess risk, have been
shown to be at most only weakly related to ciga-
rette smoking; some studies have shown no asso-
ciation at all. The authors also noted that large-
cell differentiated carcinoma of the lung,
accounting for the vast majority of the excess
lung cancer risk, is the only major histological
type that has never been related to cigarette
smoking by epidemiologic study. Thus, they con-
cluded that cigarette smoking was not a major
confounding variable in the study.
A further study was made by Waxweiler et al.
to test whether one or more chemicals used at the
plant were responsible for the excess oflung can-
cer oftypes 3 and 4 or forthe excess ofonly type 4.
A model was specifically developed for this pur-
pose. The sensitivity and specificity ofthe model
was demonstrated by its confirmation ofthe rela-
tionship between angiosarcoma of the liver and
direct vinyl chloride exposure. The authors re-
ported that ofall 19 chemicals used at the plant,
poly(vinyl chloride) dust was the only chemical
for which they found a statistically significant
association with lungcancermortality and specifi-
cally with large-cell undifferentiated lung cancer.
The studies mentioned above suggest that the
excess lung cancer risk in the vinyl chloride-
poly(vinyl chloride) industry is related to expo-
sure to poly(vinyl chloride) dust. That the dust
itself or as a carrier of residual vinyl chloride
monomer is a factor in the etiology oflung cancer
seems biologically plausible. Poly(vinyl chloride)
dust particles are known to be often in the respi-
rable range-that is, less than 10 gm in diame-
ter. Almost all poly(vinyl chloride) particles pro-
duced by the emulsion system, one ofthe systemsTOXICITY OF VINYL CHLORIDE AND PVC 65
at the facility studied by Waxweiler et al., are in
the respirable range. These particles could easily
settle in the lung and conceivably by themselves
cause lung cancer. However, it is known that
vinyl chloride monomer becomes entrapped in
poly(vinyl chloride) dust and can be released
slowly over time. Thus it is also possible that
poly(vinyl chloride) dust particles in the lung
could slowly release vinyl chloride monomer to
small adjacent areas ofthe tissue, prolonging the
contact time ofthat chemical with tissue.
On the basis of these findings, one must seri-
ously question the safety of the current OSHA
standard for poly(vinyl chloride) dust, i.e., a stan-
dard which treats poly(vinyl chloride) as a nui-
sance dust.
Community Exposure to Vinyl
Chloride
Christine et al. (30) reported two cases of he-
patic angiosarcoma in Connecticut having a prob-
able residential exposure to vinyl chloride. One
individual with hepatic angiosarcoma lived
within 2 miles of the plant producing poly(vinyl
chloride)-coated wire, while the second individual
lived within 0.5 miles of a plant producing vinyl
sheets. Each ofthese two plants also had a case of
hepatic angiosarcoma among its labor force. Nei-
ther ofthese residential cases was known to have
had occupational exposure to vinyl chloride or
arsenic or diagnostic exposure to thorium dioside,
the only three agents known to cause hepatic
angiosarcoma in humans. Baxter et al. (31), in
1977 reported another case ofliver angiosarcoma
in Great Britain who had lived for 6 years within
half a mile of a plant manufacturing poly(vinyl
chloride). On the basis of these observations,
Brady et al. (41) in 1977 undertook a study in
New York State of 26 confirmed cases of hepatic
angiosarcoma. Controls comprised of individuals
who had an internal malignant tumor other than
primary liver cancer were matched with index
cases on the basis of age at diagnosis, race, sex,
place of residence and vital status. This study
showed a statistically significant association be-
tween angiosarcoma of the liver and direct occu-
pational or therapeutic exposure to arsenic (two
cases), vinyl chloride (three cases) and thorium
dioxide (two cases). In addition, this study demon-
strated that often female cases ofliver angiosar-
coma (no direct occupational or therapeutic expo-
sure to vinyl chloride, arsenic orthorium dioxide)
one lived within 1700 ft of a vinyl chloride poly-
merizarion plant and four lived from 500 to 4500
ft of a poly(vinyl chloride) fabrication plant. In
contrast, none of their matched controls lived
within 1 mile of any facility polymerizing vinyl
chloride or fabricating poly(vinyl chloride). These
study findings are supportive of the role of in-
direct modes of vinyl chloride exposure in the
etiology ofliver angiosarcoma.
Summary
Adenomas and adenocarcinomas of the lung,
angiosarcomas of the liver and of other sites,
lymphomas, mammary carcinomas, neuroblasto-
mas of the brain, in addition to various other
tumors have been induced in mice, rats and ham-
sters exposed by inhalation to vinyl chloride. In
addition vinyl chloride when administered by in-
halation has been found to induce hepatic and
extrahepatic angiosarcomas at concentrations as
low as 10 ppm and mammary carcinomas at even
lower concentrations, i.e., 5 and 1 ppm.
Several mutually confirmatory studies, using
the retrospective cohort method, have shown an
increased risk ofliver angiosarcoma and cancer of
other sites among employees of vinyl chloride
polymerization facilities. The full magnitude of
this site-specific cancer risk among employees of
vinyl chloride polymerization plants will only be
determined following full lifetime observation.
Nevertheless, studies already have shown that
for liver angiosarcoma the excess risk is approxi-
mately 11 to 16 times that ofthe general popula-
tion. For brain cancer the excess risk is 4-fold.
The role of indirect modes of exposure to vinyl
chloride has now been shown to be associated
with an excess risk of cancer. Several cases of
liver angiosarcoma have been reported among
individuals living in close proximity (less than 2
miles) to facilities polymerizing vinyl chloride or
fabricating poly(vinyl chloride). A recent epide-
miological study has demonstrated that 50% of
females with liver angiosarcoma (5/10) lived
within 1 mile of such industrial facilities,
whereas none oftheir matched control did so.
Experimental bioassay and epidemiological
studies have shown a high concordance for the
carcinogenicity of vinyl chloride, specifically for
liver angiosarcoma. This excess ofliver angiosar-
coma has been shown to persist from the polymer-
ization of vinyl chloride to the residence in near
proximity to such facilities.
Both experimental and epidemiological data
indicate that PVC dust is probably associated
with respiratory effects, both neoplastic and non-
neoplastic in nature.
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